The 30-month stay in the RAZADYNE(R) cases filed by Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., expires in late August 2008.
In the action against Barr Laboratories, Inc. and AlphaPharm with…
A jury in the U.S. District Court for the District of California returned a verdict in Microsoft Corporation’s favor on June 4, 2008, finding no infringement of Alcatel-Lucent’s patent.
The jury…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., intends to appeal the summary judgment decision invalidating the claims of U.S. Patent No. 39,221 (reissue patent).
The ‘221 patent claims combinations of acetaminophen…
Microsoft Corporation is appealing the reversal of the U.S. International Trade Commission infringement ruling against Alcatel-Lucent to the U.S. Court of Appeals for the Federal Circuit.
In February 2007, the Company…
The Court of Appeals for the Federal Circuit, on July 21, 2008, affirmed the decision upholding the enforceability of the patent on ACIPHEX(R), according to Johnson & Johnson’s Form 10-Q…
Johnson & Johnson’s subsidiary, Ortho-McNeil Pharmaceutical Inc., continues to be in a dispute with Sandoz Inc. over its challenges to the RAZADYNE(R) ER patents.
In the action against Sandoz with respect…
Cordis Corp., a Johnson & Johnson subsidiary, pursues several patent infringement lawsuits in New Jersey Federal District Court against Guidant Corporation, Abbott Laboratories, Inc., Boston Scientific Corporation and Medtronic AVE,…
Johnson & Johnson and its subsidiaries continue to face patent infringement actions filed by Boston Scientific Corporation in certain European countries, including Belgium, the Netherlands, France, and Germany.
Boston Scientific has…
The Federal District Court in Delaware has yet to issue its ruling in Ortho-McNeil Pharmaceutical Inc.’s CONCERTA(R) patent suit against Andrx Corporation.
Ortho-McNeil is a Johnson & Johnson subsidiary.
In the action…
Schering-Plough Corp. is pursuing patent infringement actions against companies seeking approval of generic versions of Clarinex Tablets, Clarinex Reditabs and Clarinex D12.
The Company filed these actions in September 2006. (Lloyds…